Monday, August 31, 2026
NewsWhite
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
WORLD
Unverified

Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

July 22, 2026Source: CNBC0 views

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.

This story was originally reported by CNBC. For the complete coverage and latest updates, visit the original source.

Read the full story at CNBC.

Originally reported by CNBC. Read the original article

Related Articles